FindMyKOL

Timothée Olivier, MD

Enriched profile

Médecin adjoint agrégé (attending physician), Service d'oncologie, Département d'oncologie, HUG, since 1 November 2023 · Geneva University Hospitals (HUG)

ORCID↗NPINone on file
✓ Itemized profile
RegionNot on fileSpecialtyMedicineFocusStatistical Methods in Clinical Trials+4
ActivityNone indexedFindMyKOL type: RegionalLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH fundingNone on fileWhy? →

Timothée Olivier is Médecin adjoint agrégé (attending physician), Service d'oncologie, Département d'oncologie, HUG, since 1 November 2023 at Geneva University Hospitals (HUG). OpenAlex indexes 127 publications with 2,019 citations (h-index 23).

Data verified 8 Nov 2026

Overview

Updated 8 Nov 2026

Timothée Olivier is Médecin adjoint agrégé (attending physician), Service d'oncologie, Département d'oncologie, HUG, since 1 November 2023 at Geneva University Hospitals (HUG), Department of Oncology, Medical Oncology Service. The public record shows 127 publications with 2,019 citations (h-index 23), centered on Statistical Methods in Clinical Trials, Cancer Immunotherapy and Biomarkers, Pharmaceutical industry and healthcare.

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Statistical Methods in Clinical Trials

Generated from the cited public record · current as of 8 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
SarcomaLung Cancer (NSCLC/SCLC)MelanomaOvarian / Gynecologic CancerMultiple MyelomaCOVID-19Breast CancerColorectal CancerNeuro-Oncology / GliomaCushing's SyndromeAcromegalyLeukemia (AML/ALL/CML/CLL)Prostate CancerPancreatic CancerBladder / Urothelial CancerHead & Neck Cancer

Research focus

OpenAlex concept fingerprint
Statistical Methods in Clinical TrialsCancer Immunotherapy and BiomarkersPharmaceutical industry and healthcareLung Cancer Treatments and MutationsPARP inhibition in cancer therapy

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
127publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

2,019citations

Citations across these publications.

23h-index

H-index from these publications. i10-index 46.

Clinical & industry

trials, payments and federal funding
—clinical trials

Not shown. No U.S. clinical registration on file.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 8 Nov 2026

6 congress contributions (2007–2025) across ASCO, ASTRO, ESMO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 8 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 8 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Congress posts on X

Post links from an X account tied to this person through reviewed identity evidence.

  1. Listed under ESMO 2026

    Collection sources

    Collected .

  2. Listed under ESMO 2026

    Collection sources

    Collected .

  3. Listed under ESMO 2026

    Collection sources

    Collected .

These links cover selected congress pages. They do not establish attendance or a complete posting history. Post availability may change.

Online presence

Updated 8 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • X / Twitter

    x.com/Timothee_MD

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    hug.ch/oncologie/dr-timothee-olivier

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hug.ch ↗
  • Oncodaily.com

    Profiled as an OncoInfluencer to follow on social media (OncoDaily)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 8 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Member

    Cantonal Research Ethics Commission (CCER), Geneva

    2023
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hug.ch ↗
  • Co-Editor-in-Chief

    ESMO Rare Cancers

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hug.ch ↗

Secondary affiliations

appointments beyond the home institution
  • Privat-Docent

    University of Geneva

    2024
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hug.ch ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.